“The other thing that may not be priced into the market is the fact that this virus may take another 18 to 24 months to really cycle through the globe, and ultimately have a vaccine,” he added. The coronavirus pandemic has infected over 2.4 million people globally, with the U.S. reporting the highest number of cases worldwide — around 760,000, according to data compiled by Johns Hopkins University.
The rapid spread prompted states across the U.S. to impose lockdown measures of varying degrees, which caused unemployment to spike as businesses struggle to stay afloat. With the pandemic potentially dragging out a lot longer, Bailin said he has “significantly” lower expectations for company earnings compared to most analysts. He explained that the degree to which the coronavirus pandemic hit businesses in March would “hint” at what will happen in the coming quarters.
“In the second quarter we expect earnings to literally fall by 40% or more across the board, and we don’t expect earnings in the United States to get back to their first quarter levels for nine quarters from now,” he said. That doesn’t mean that investors should stay out of U.S. financial markets. Instead, Bailin said there are some good opportunities in the markets stateside.
US markets haven’t priced in a ‘significant second wave’ of coronavirus, says Citi Private Bank, CNBC, Apr 20